Patents by Inventor Jennifer Keating

Jennifer Keating has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11950907
    Abstract: A method of assessment of renal function by monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a diffuse reflecting medium with time-varying optical properties is provided that includes using a renal monitoring system comprising at least one light source, at least one light detector, at least one optical filter, and at least one controller to provide a measurement data set comprising a plurality of measurement entries, each measurement data entry comprising at least two measurements obtained at one data acquisition time from a patient before and after administration of the fluorescent agent.
    Type: Grant
    Filed: September 16, 2022
    Date of Patent: April 9, 2024
    Assignee: MEDIBEACON, INC.
    Inventors: Kimberly Shultz, Jennifer Keating, Edward Solomon, Kate Bechtel
  • Publication number: 20230021174
    Abstract: A method of assessment of renal function by monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a diffuse reflecting medium with time-varying optical properties is provided that includes using a renal monitoring system comprising at least one light source, at least one light detector, at least one optical filter, and at least one controller to provide a measurement data set comprising a plurality of measurement entries, each measurement data entry comprising at least two measurements obtained at one data acquisition time from a patient before and after administration of the fluorescent agent.
    Type: Application
    Filed: September 16, 2022
    Publication date: January 19, 2023
    Inventors: Kimberly Shultz, Jennifer Keating, Edward Solomon, Kate Bechtel
  • Patent number: 11478172
    Abstract: A method of assessment of renal function by monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a diffuse reflecting medium with time-varying optical properties is provided that includes using a renal monitoring system comprising at least one light source, at least one light detector, at least one optical filter, and at least one controller to provide a measurement data set comprising a plurality of measurement entries, each measurement data entry comprising at least two measurements obtained at one data acquisition time from a patient before and after administration of the fluorescent agent.
    Type: Grant
    Filed: March 12, 2021
    Date of Patent: October 25, 2022
    Assignee: MediBeacon Inc.
    Inventors: Kimberly Shultz, Jennifer Keating, Edward Solomon, Kate Bechtel
  • Publication number: 20210219883
    Abstract: A method of assessment of renal function by monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a diffuse reflecting medium with time-varying optical properties is provided that includes using a renal monitoring system comprising at least one light source, at least one light detector, at least one optical filter, and at least one controller to provide a measurement data set comprising a plurality of measurement entries, each measurement data entry comprising at least two measurements obtained at one data acquisition time from a patient before and after administration of the fluorescent agent.
    Type: Application
    Filed: March 12, 2021
    Publication date: July 22, 2021
    Inventors: Kimberly Shultz, Jennifer Keating, Edward Solomon, Kate Bechtel
  • Patent number: 10980459
    Abstract: A method of monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a medium with time-varying optical properties is provided that includes providing a measurement data set that includes a plurality of measurement entries that include at least two measurements obtained from a patient before and after administration of the fluorescent agent. The measurements may include one or more of: a DRex signal detected by an unfiltered light detector during illumination by excitatory-wavelength light from first region adjacent to the diffuse reflecting medium; a Flr signal detected by a filtered light detector during illumination by excitatory-wavelength light; and a DRem signal detected by the unfiltered light detector during illumination by emission-wavelength light.
    Type: Grant
    Filed: December 17, 2019
    Date of Patent: April 20, 2021
    Assignee: MediBeacon Inc.
    Inventors: Kimberly Shultz, Jennifer Keating, Edward Solomon, Kate Bechtel
  • Publication number: 20200383617
    Abstract: A sensor head is provided comprising a housing enclosing at least two light sources configured to deliver light to a patient and comprising a blue LED first light source that delivers light at an excitatory wavelength and a green LED second light source, and at least one light detector configured to detect light at an emission wavelength from the patient. The sensor is useful for non-invasive monitoring of fluorescent tracers agents.
    Type: Application
    Filed: August 24, 2020
    Publication date: December 10, 2020
    Inventors: Kimberly Shultz, Jennifer Keating, Edward Solomon, Kate Bechtel
  • Publication number: 20200138352
    Abstract: A method of monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a medium with time-varying optical properties is provided that includes providing a measurement data set that includes a plurality of measurement entries that include at least two measurements obtained from a patient before and after administration of the fluorescent agent. The measurements may include one or more of: a DRex signal detected by an unfiltered light detector during illumination by excitatory-wavelength light from first region adjacent to the diffuse reflecting medium; a Flr signal detected by a filtered light detector during illumination by excitatory-wavelength light; and a DRem signal detected by the unfiltered light detector during illumination by emission-wavelength light.
    Type: Application
    Filed: December 17, 2019
    Publication date: May 7, 2020
    Inventors: Kimberly Shultz, Jennifer Keating, Edward Solomon, Kate Bechtel
  • Patent number: 10548521
    Abstract: A method of monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a medium with time-varying optical properties is provided that includes providing a measurement data set that includes a plurality of measurement entries that include at least two measurements obtained from a patient before and after administration of the fluorescent agent. The measurements may include one or more of: a DRex signal detected by an unfiltered light detector during illumination by excitatory-wavelength light from first region adjacent to the diffuse reflecting medium; a Flr signal detected by a filtered light detector during illumination by excitatory-wavelength light; and a DRem signal detected by the unfiltered light detector during illumination by emission-wavelength light.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: February 4, 2020
    Assignee: MediBeacon Inc.
    Inventors: Kimberly Schultz, Jennifer Keating, Edward Solomon, Kate Bechtel
  • Patent number: 10194854
    Abstract: A method of monitoring a time-varying fluorescence emitted from a fluorescent agent from within a diffuse reflecting medium with time-varying optical properties is disclosed that includes providing at least two measurements obtained from a patient before and after administration of the fluorescent agent that includes an Flrmeas signal detected adjacent to the medium by a filtered light detector during illumination of the medium by excitatory-wavelength light, and at least one DR signal selected from: a DRexmeas DRem, and DRem,filtered signal. The method further includes identifying a post-equilibration portion of the measurement data set and transforming each Flrmeas signal within the post-equilibration portion of the measurement data set to an IFagent signal representing a detected fluorescence intensity emitted solely by the fluorescent agent from within the medium.
    Type: Grant
    Filed: January 30, 2018
    Date of Patent: February 5, 2019
    Assignee: MediBeacon Inc.
    Inventors: Jennifer Keating, Kimberly Shultz, Kate Bechtel, Edward Solomon
  • Publication number: 20180214062
    Abstract: A method of monitoring a time-varying fluorescence emitted from a fluorescent agent from within a diffuse reflecting medium with time-varying optical properties is disclosed that includes providing at least two measurements obtained from a patient before and after administration of the fluorescent agent that includes an Flrmeas signal detected adjacent to the medium by a filtered light detector during illumination of the medium by excitatory-wavelength light, and at least one DR signal selected from: a DRexmeas DRem, and DRem,filtered signal. The method further includes identifying a post-equilibration portion of the measurement data set and transforming each Flrmeas signal within the post-equilibration portion of the measurement data set to an IFagent signal representing a detected fluorescence intensity emitted solely by the fluorescent agent from within the medium.
    Type: Application
    Filed: January 30, 2018
    Publication date: August 2, 2018
    Inventors: Jennifer Keating, Kimberly Shultz, Kate Bechtel, Edward Solomon
  • Publication number: 20180214057
    Abstract: A method of monitoring a time-varying fluorescence signal emitted from a fluorescent agent from within a medium with time-varying optical properties is provided that includes providing a measurement data set that includes a plurality of measurement entries that include at least two measurements obtained from a patient before and after administration of the fluorescent agent. The measurements may include one or more of: a DRex signal detected by an unfiltered light detector during illumination by excitatory-wavelength light from first region adjacent to the diffuse reflecting medium; a Flr signal detected by a filtered light detector during illumination by excitatory-wavelength light; and a DRem signal detected by the unfiltered light detector during illumination by emission-wavelength light.
    Type: Application
    Filed: January 30, 2018
    Publication date: August 2, 2018
    Inventors: Kimberly Schultz, Jennifer Keating, Edward Solomon, Kate Bechtel